Emily Kaiser Maharjan, Assistant Managing Editor

Catch up on what happened in optometry during the week of January 8-January 12.

Harrow’s Vevye is the first and only cyclosporine-based product approved for the treatment of both signs and symptoms of dry eye disease.

AR-15512 is a topical transient receptor potential melastatin 8 (TRPM8) agonist designed to treat the signs and symptoms of DED via increased tear production.

Catch up on what happened in optometry during the week of January 1-January 5.

Catch up on what happened in optometry during the week of December 25-December 29.

A report by Technavio indicates that lifestyle changes will increase eyewear sales across the globe.

From FDA approvals to innovations in lens tech, 2023 was a big year in eye care.

Catch up on what happened in optometry during the week of December 18-December 22.

Damon Dierker, OD, FAAO, shares latest updates in research on sutureless cryopreserved amniotic membrane for moderate-to-severe dry eye with short treatment duration.

Catch up on what happened in optometry during the week of December 11-December 15.

Eye care witnessed a transformative year with 11 FDA approvals. As the year concludes, there remains a robust pipeline of drugs, setting high expectations for continued advancements in ophthalmological care in 2024 and beyond.

A research report compiled by The Vision Council reveals that most parents are aware of myopia but remain in the dark about prevalence and how to prevent progression.

The multidisciplinary program aims to bring myopia management tools to under-resourced children across the US.

Catch up on what happened in optometry during the week of December 4-December 8.

Dr Mile Brujic discusses his EyeCon presentations, which spanned from antibody drug conjugates (ADCs) and their effect on ocular toxicity for patients with cancer to innovations in eye care.

Catch up on what happened in optometry during the week of November 27-December 1.

Catch up on what happened in optometry during the week of November 20-November 24.

Using the NEI protocol for addressing corneal staining, researchers used 5 microliters of 2%, non preserved fluorescein and then evaluated corneal staining.

Hear about the new innovations on the market—and coming soon—from Alcon.

ONE by ONE and Biotrue Eye Care Recycling programs from Bausch + Lomb have collected over 464,100 pounds of used contact lens materials that would have otherwise been sent to a landfill.

A rapid-fire, top-level review of what happened in optometry in 2023.

Hear how this daily disposable silicone hydrogel option fits patients' busy and active lifestyles.

Hear how the Clek study continues to play a role in today's keratoconus care.

Optometry Times sat down with Carla Calizaire, Global Leader of Diversity Inclusion for Johnson and Johnson Med Tech to go in depth about the Vision Made Possible and Sight for Kids campaign.

The 2023 American Academy of Optometry annual meeting showcased excellent science and insightful education.

Patients who have signs or symptoms of an eye infection after using these products should talk to their health care provider or seek medical care immediately.

The FDA recalled 26 eye drops due to risk of infection and possible vision loss.

Optometrists must consider the experience of the person in the chair.

At the 2023 AAOpt annual meeting, data was presented on the frequency of success of patients struggling with contact lens drop out getting back into daily disposable lenses.

Traditionally hosted in New York City, Vision Expo East will be held in Orlando, Florida, beginning in 2025.